Clinical Trial Update: A Retrospective Non Interventional Study on First Line Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)

View source ↗

Summary

A retrospective non-interventional study assessed first-line treatment outcomes in patients with BRAFV600E-mutant metastatic colorectal cancer, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Pierre Fabre Medicament | Conditions: BRAF V600E Mutation Positive, Metastatic Colorectal Cancer | Status: COMPLETED | Results posted: 2024-07-15